Eli Lilly and Company News Releases

Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries

- Donation builds upon Lilly's access principles for COVID-19 therapies INDIANAPOLIS , May 4, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) is donating COVID-19 therapies to Direct Relief, enabling the humanitarian organization to provide COVID-19 therapies at no cost to low- and
favicon
investor.lilly.com
investor.lilly.com